Tag: <span>COVID-19</span>

Home / COVID-19
Post

CAN BLOOD SUGAR CONTROL PROTECT AGAINST COVID’S WORST EFFECTS?

A new algorithm for monitoring glucose may help combat serious complications from COVID-19 in patients with diabetes or high blood sugar, researchers say. After preliminary observations of 200 COVID-19 patients with severe hyperglycemia, a new Diabetes paper sheds light on why high blood sugar may trigger worse outcomes in people infected with the virus. “THIS...

Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective
Post

Preliminary study of 300+ COVID-19 patients suggests convalescent plasma therapy effective

American Journal of Pathology publishes efficacy results from Houston Methodist clinical trial HOUSTON METHODIST HOUSTON METHODIST PHYSICIAN SCIENTIST ERIC SALAZAR, MD, PHD, LOOKS ON AS HIS TEAM WORKS IN THE LAB ON CONVALESCENT PLASMA RESEARCH. view more CREDIT: HOUSTON METHODIST HOUSTON-(Aug. 12, 2020) – A preliminary analysis of an ongoing study of more than 300...

Post

Does high blood sugar worsen COVID-19 outcomes?

Preliminary observations of COVID-19 patients with diabetes inspired an algorithm for glucose monitoring that’s suspected to help combat the virus’ serious complications MICHIGAN MEDICINE – UNIVERSITY OF MICHIGAN As COVID-19 continues to rage across the U.S., researchers are digging deeper into how the virus wreaks havoc on the body, especially for those with a pre-existing...

Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19
Post

Novateur Ventures explores new strategy to reduce hyperinflammatory response caused by COVID-19

VASCULAR LEAKAGE, INFLAMMATION-PROVOKING, AND THROMBOTIC EVENTS IN CORONAVIRUS DISEASE 2019 view more CREDIT: NOVATEUR VENTURES A novel strategy has been developed by Novateur Ventures, which provides new hope in battle against COVID-19. The study titled ‘A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes’ was published in Frontiers in Pharmacology, a...

55% of coronavirus patients still have neurological problems three months later: study
Post

55% of coronavirus patients still have neurological problems three months later: study

Could the coronavirus lead to chronic illness? While lung scarring, heart and kidney damage may result from COVID-19, doctors and researchers are starting to clock the potential long-term impact of the virus on the brain also. Younger COVID-19 patients who were otherwise healthy are suffering blood clots and strokes. And many “long-haulers,” or COVID-19 patients...

Chinese Study Finds COVID-19 Patients Still Suffer From Lung Damage Three Months After Being Discharged
Post

Chinese Study Finds COVID-19 Patients Still Suffer From Lung Damage Three Months After Being Discharged

A new study found the majority of Chinese patients recovering from COVID-19 still suffer from lung damage three months after being discharged from the hospital. Zhongnan Hospital of Wuhan University Intensive Care Director Dr. Peng Zhiyong published his findings on his research on the impact of COVID-19 on patients’ health after recovery. This was the...

Post

COVID-19: Immune system derails

DZNE – GERMAN CENTER FOR NEURODEGENERATIVE DISEASES Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction – rather, the immune response is caught in a continuous loop of activation and inhibition. Experts from Charité – Universitätsmedizin Berlin, the University of Bonn,...

Post

Boosting immune system a potential treatment strategy for COVID-19

by Jim Dryden, Washington University School of Medicine in St. Louis Front-line health-care providers work with seriously ill COVID-19 patients in an intensive care unit at Barnes-Jewish Hospital in St. Louis. New research from scientists at Washington University School of Medicine suggests that the immune systems of such patients can’t do enough to protect them...